
As the chances for passage of pharmaceutical pricing and oversight bills fade in Congress and the White House, there is a bit of good news on that front from the Department of Justice (DOJ). Three generic drug makers have agreed to pay $447.2 million to resolve price-fixing allegations related to... Read More »